Strong finish of the year with multiple RayStation orders

RaySearch Laboratories AB has received seven orders for its RayStation®
treatment planning system in December from clinics in Belgium, Germany, New
Zealand and USA.

The German order comes from Universitätsklinikum Essen in Essen and the order in
Belgium comes from The Europe Hospitals in Brussels which is the first
RayStation® customer in Belgium. Europe Hospitals will initially use RayStation®
for treatment planning of rotational therapy with Siemens linear accelerators.

“The Brussels Europe Hospitals make up the largest group of private clinics in
Brussels. Our new radiation oncology department continuously invests in the
latest technology with a clear long term vision. The next step is to clinically
implement rotational IMRT and RayStation® clearly stands out as the best
treatment planning option on the market for this new exciting technique.
RayStation® has a modern workflow and is based on state-of-the-art algorithms so
we are looking forward to start using the system clinically”, says Dr. Carl
Salembier, Head of the Radiation Oncology department at Europe Hospitals St
-Elisabeth.

RaySearch has also received the first order from New Zealand. The private
radiation therapy facility Auckland Radiation Oncology in Auckland has ordered
RayStation® as a replacement for the clinic’s existing treatment planning system
and will use it for all forms of radiation therapy from conventional 3D-CRT to
more advanced techniques such as VMAT and adaptive radiation therapy.

In the US, RaySearch has received four RayStation® orders from Akron General
Hospital in Akron, Ohio; California Cancer Center in Fresno, California; XRAD
Services in Philadelphia, Pennsylvania, and Littleton Radiation Oncology Center
in Denver, Colorado. The clinics will use RayStation® for all sorts of radiation
treatments using advanced tools such as Multi-Criteria Optimization, a new
paradigm in IMRT planning and Dose Tracking which enables treatment adaptation.

David Schreiber, MD, is the CEO and Medical Director of The Littleton Radiation
Oncology Center which is an independent cancer treatment facility that provides
a blend of leading-edge technology and individual attention. Dr. Schreiber
comments: “The purchase of this new and unique treatment planning system will
allow Littleton Radiation Oncology to be the first and only radiation oncology
facility in the state of Colorado to offer 4D treatment planning, which will
allow us to provide enhanced IMRT delivery, a process by which treatments can be
customized in real time each day. This will translate into an even lower dose of
radiation to the surrounding normal tissues, which should in turn translate into
a much lower risk of side effects.”

Johan Löf, CEO of RaySearch Laboratories AB adds: “We strongly believe that
RayStation® is the leading treatment planning system on the market today and we
are thrilled to see that an increasing number of customers are joining us. So
far during the fourth quarter of 2012, we have received RayStation® orders with
an accumulated order value of more than SEK 50 M and, in addition, we have
negotiations going on with numerous other clinics. All of these systems will not
be delivered and invoiced during the fourth quarter, but the revenues from
RayStation® will still be the highest that we have ever recorded for one
quarter.”

About RayStation®
RayStation® integrates all RaySearch’s advanced treatment planning solutions
into a flexible treatment planning system. It combines unique features such as
multi-criteria optimization tools with full support for 4D adaptive radiation
therapy. It also includes functionality such as RaySearch’s market-leading
algorithms for IMRT and VMAT optimization and highly accurate dose engines for
both photon and proton therapy. The system is built on the latest software
architecture and has a graphical user interface offering state-of-the-art
usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch’s
products are mainly sold through license agreements with leading partners such
as Philips, Nucletron, IBA Dosimetry, Varian, Accuray and Siemens. To date, 15
products have been launched through partners and RaySearch’s software is used at
over 2,000 clinics in more than 30 countries. In addition, RaySearch offers the
proprietary treatment planning system RayStation® directly to clinics. RaySearch
was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and
the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.

For more information about RaySearch, visit www.raysearchlabs.com


For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com